FFIV
66
-4
CAT
59
-2
REGN
38
-2
TXT
53
-3
VNO
46
-13
DG
8
-2
EXPD
43
-4
STX
45
-4
BEN
50
9
CMG
66
-4
FSLR
44
-2
AAPL
40
-6
SYY
49
9
CL
54
3
PCAR
56
-5
SHW
62
-6
BBY
52
6
MAS
52
-4
CHD
54
4
EL
15
-3
FFIV
66
-4
CAT
59
-2
REGN
38
-2
TXT
53
-3
VNO
46
-13
DG
8
-2
EXPD
43
-4
STX
45
-4
BEN
50
9
CMG
66
-4
FSLR
44
-2
AAPL
40
-6
SYY
49
9
CL
54
3
PCAR
56
-5
SHW
62
-6
BBY
52
6
MAS
52
-4
CHD
54
4
EL
15
-3
Financhill
Back

Meritage Homes Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
56

MTH
Meritage Homes

Last Price:
179.37
Seasonality Move:
11.82%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
56
Meritage Homes (MTH) is a Buy

Is Meritage Homes a Buy, Sell or Hold?

  • The current Meritage Homes [MTH] share price is $179.41. The Score for MTH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • MTH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MTH Stock Price Chart

What is Meritage Homes's stock price today?

  • The Meritage Homes share price today is $179.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTH is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

MTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.21 Sell
Relative Strength Index (14 RSI): 40.67 Sell
Chaikin Money Flow: -363319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (180.02 - 194.62) Sell
Bollinger Bands (100): (174.81 - 201.99) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

MTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 184.31 Sell
20-day SMA: 184.36 Sell
50-day SMA: 193.54 Sell
200-day SMA: 176.34 Buy
8-day EMA: 182.76 Sell
20-day EMA: 185.86 Sell
50-day EMA: 189.2 Sell
200-day EMA: 177.19 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Meritage Homes Earnings Growth & MTH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.54 per share, and an increase next year of $0.05 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Meritage Homes Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):